Flu Prebook ending January 30, 2026, and VFC Updates

Wisconsin Department of Health Services

Wisconsin Vaccines for Children Program (VFC)

Flu Prebook ending January 30, 2026, and VFC Updates

This message is being sent to VFC providers, local health officers, local health nurses, local health staff, Tribal health directors, and key DHS staff. 

Flu prebook

Don’t forget to prebook your 2026 flu prebook before the close of business on January 30, 2026.

The prebook ends on January 30, 2026 for all VFC providers as well as local and Tribal health departments (LTHDs) who wish to do mass exercise(s). If you need the instructions you can refer to the messages from January 14 2026-2027 VFC Flu Vaccine Prebook and 2026–2027 Flu Vaccine Mass Vaccination Exercises Prebook for Local and Tribal Health Departments


VFC open forum

The Vaccines for Children Program (VFC) and the Wisconsin Immunization Registry (WIR) units will hold an open forum session to give you an opportunity to ask questions that you may have about VFC, vaccine ordering, WIR, WIR reports, and more. After the presentation there will be open Q&A.

This session is scheduled for February 4, from 11:30 a.m.–12:15 p.m. 

Join via zoom 

Participation is not required, but is being offered as another tool for you to connect with VFC and WIR staff from the Immunization Program.

These open forum sessions are held once a month. Please save the following dates for future VFC open forums:

  • March 4, 2026, 11:30 a.m.–12:15 p.m.
  • April 1, 2026, 11:30 a.m.-12:15 p.m.
  • May 6, 2026, 11:30 a.m.-12:15 p.m.

Maternal RSV vaccine

Seasonal maternal vaccination for RSV ends on January 31. Maternal RSV vaccination is recommended between September 1 and January 31 for those who are 32–36 weeks pregnant.

Please remember to keep any unexpired product that you have left in the refrigerator from the current season, so you have start up stock for next season.

Immunization for infants against RSV with Beyfortus (nirsevimab) or Enflonsia (clesrovimab) continues through March 31. Continue to protect vulnerable infants by administering RSV monoclonal antibody products through the end of the infant administration season.